Knoll Capital Management as of June 30, 2014
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 15 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 78.3 | $176M | 2.3M | 77.08 | |
| Ampio Pharmaceuticals | 11.0 | $25M | 3.0M | 8.35 | |
| Alcobra | 5.3 | $12M | 687k | 17.31 | |
| Keryx Biopharmaceuticals | 1.4 | $3.1M | 200k | 15.38 | |
| Synthetic Biologics | 1.1 | $2.4M | 1.4M | 1.76 | |
| Newlink Genetics Corporation | 0.9 | $2.1M | 77k | 26.55 | |
| Northwest Biotherapeutics In (NWBO) | 0.6 | $1.3M | 200k | 6.71 | |
| Inovio Pharmaceuticals | 0.5 | $1.1M | 102k | 10.86 | |
| Advaxis | 0.3 | $709k | 225k | 3.15 | |
| Galmed Pharmaceuticals | 0.3 | $633k | 65k | 9.74 | |
| Nephrogenex | 0.1 | $301k | 50k | 6.02 | |
| Provectus Biopharmaceuticals I (PVCT) | 0.1 | $172k | 200k | 0.86 | |
| Advaxis Inc. w exp 07/15/201 | 0.1 | $115k | 113k | 1.02 | |
| Echo Therapeutics | 0.0 | $62k | 27k | 2.26 | |
| Celsus Therapeutics Plc sponsored adr ne | 0.0 | $78k | 14k | 5.51 |
